Evaluation of the Effect of Immediate and Early Skin-to-Skin Contact After Cesarean on Maternal and Neonatal Parameters in the First 24 Hours: A Quasi-Experimental Study
SSC
1 other identifier
interventional
92
1 country
1
Brief Summary
This study was carried out as a quasi-experimental study to determine the effects of immediate and early skin-to-skin contact (SSC) applied between mother and newborn after cesarean on breastfeeding, anxiety, bleeding and newborn health in the first 24 hours. The application of the study carried out in the cesarean operating room and gynecology services of a private hospital. The required institutional permission and ethics committee approval was received. The sample consisted of 92 mother-infant couples totally, 30 of whom selected to immediate skin-to-skin contact (ISSC), 29 of whom selected to early skin-to-skin contact (ESSC), 33 of whom selected to the control group. The data was collected using Prenatal and postnatal data collection form, Breastfeeding Assessment Tool Scale (IBFAT), The State-Trait Anxiety Inventory and Maternal and newborn follow-up chart for the first 24 hours postpartum. In ISSC group, skin contact was applied within the first 5 minutes after cesarean, and applied to the ESSC group within the first hour after cesarean, and skin contact lasted 40 minutes. The data stored in the SPSS 24 program. In the analysis of the data, Independent Sample-t test, ANOVA test, Paired Sample-t test, Mann-Whitney U test, Kruskal-Wallis H test, Wilcoxon test, Bonferroni correction, Pearson and Spearman correlation coefficient and χ2 test used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2020
CompletedFirst Submitted
Initial submission to the registry
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedApril 15, 2026
April 1, 2026
1.2 years
March 1, 2026
April 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Breastfeeding Assessment Tool Scale (IBFAT)
IBFAT administered to women at the first beastfeeding and postpartum 24th hour to assess breastfeed success.
Within 24 hours after cesarean section
The State-Trait Anxiety Inventory (STAI)
Mothers asked to fill out STAI at postpartum 2nd hour for all groups to assess the anxiety levels.
Postpartum 2nd hour
Maternal hemorrhage
Total Maternal hemorrhage (grams) amounts were measured in all groups at 24 hours postpartum.
Within 24 hours after cesarean section
Body temperature of newborns
Body temperatures (°C) of newborns were measured with thermometer.
Within 24 hours after cesarean section
Heart rates of newborns
Heart rates per minute of newborns were measured with pulse oximeter.
Within 24 hours after cesarean section
Peripheral oxygen saturation of newborns
Peripheral oxygen saturation (%) of newborns were measured with pulse oximeter.
Within 24 hours after cesarean section
Respiratory rate of newborns
Respiratory rate per minute of newborns were measured.
Within 24 hours after cesarean section
Blood glucose levels of newborns
Blood glucose levels (mg/dL) of the newborns were measured with glocometer.
Postpartum 2nd hour
Secondary Outcomes (1)
Newborns' weight loss
Postpartum 24th hour
Study Arms (1)
Skin to skin contact
EXPERIMENTALInterventions
skin to skin contact applied as an immediate and early
Eligibility Criteria
You may qualify if:
- For mothers:
- Scheduled cesarean section before spontaneous contractions begin
- Receiving epidural or spinal anesthesia
- Nulliparous
- Singleton pregnancy
- Age 18 and over
- Gestational age 37-42 weeks
- Literacy
- No known health problems (diabetes, gestational diabetes, hypertension, preeclampsia, renal failure, cardiac problems, psychiatric disorders, etc.)
- No contraindications to breastfeeding (no human T-cell lymphotropic virus (HTLV-1), human immunodeficiency virus (HIV), or active tuberculosis) Speaking Turkish
- For neonates:
- Birth weight 2500-4000 gr.
- Being between 7 and 5 minutes old
- Having an APGAR score of 7 or higher at 1 and 5 minutes
- Not having any health problems or congenital anomalies
- +1 more criteria
You may not qualify if:
- Mothers whose general condition and vital signs deteriorate during skin-to-skin contact
- Neonates who experience respiratory and circulatory problems during skin-to-skin contact
- Neonates admitted to intensive care within the first 24 hours
- Mothers who do not accumulate pads or diapers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara private hospital
Ankara, 06660, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayten ŞENTÜRK ERENEL, PhD, Prof. Dr.
Gazi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 1, 2026
First Posted
April 15, 2026
Study Start
September 20, 2018
Primary Completion
November 16, 2019
Study Completion
May 15, 2020
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share